Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Quan

Showing results (211-220 of 258) with videos related to

Pageof 26
Sort By:
Current Oncology (Toronto, Ont.)|November 11, 2020
A pan-Canadian prospective study of young women with breast cancer: the rationale and protocol design for the RUBY studyM L Quan, I A Olivotto, N N Baxter, et al.
Fa Yi Xue Za Zhi|December 13, 2017
[Correlation between Genetic Variants and Polymorphism of Caveolin and Sudden Unexplained Death]F Y Wu, X H Tang, L L Gai, et al.
Journal of Cardiovascular Pharmacology|September 1, 1995
Pharmacology of XR510, a potent orally active nonpeptide angiotensin II AT1 receptor antagonist with high affinity for the AT2 receptor subtypeP C Wong, M L Quan, J M Saye, et al.
The American Journal of Surgical Pathology|November 27, 2018
Distinct Genomic Patterns in Pigmented Epithelioid Melanocytoma: A Molecular and Histologic Analysis of 16 CasesMaria C Isales, Lauren S Mohan, Victor L Quan, et al.
Journal of the American Academy of Dermatology|October 6, 2018
The role of TERT promoter mutations in differentiating recurrent nevi from recurrent melanomas: A retrospective, case-control studyKara E Walton, Erin M Garfield, Bin Zhang, et al.
Journal of Thrombosis and Thrombolysis|August 8, 2015
In vitro, antithrombotic and bleeding time studies of BMS-654457, a small-molecule, reversible and direct inhibitor of factor XIaPancras C Wong, Mimi L Quan, Carol A Watson, et al.
Bioorganic & Medicinal Chemistry Letters|August 7, 2017
Macrocyclic factor XIa inhibitorsCailan Wang, James R Corte, Karen A Rossi, et al.
Bioorganic & Medicinal Chemistry Letters|March 5, 2018
Pyridazine and pyridazinone derivatives as potent and selective factor XIa inhibitorsZilun Hu, Cailan Wang, Wei Han, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|October 28, 2016
[Incidental internal mammary lymph node biopsy in 113 cases of breast cancer undergoingfree abdominal flap breast reconstruction and its influencing factors]C L Quan, N S Huang, B L Yang, et al.
Clinical and Experimental Dermatology|May 21, 2018
Immunohistochemical and molecular analysis of spitzoid neoplasms with pulverocyte subclonesS M Amin, A M Haugh, J A Bubley, et al.
Pageof 26

Showing results (211-220 of 258) with videos related to

Sort By:
Pageof 26
Current Oncology (Toronto, Ont.)|November 11, 2020
A pan-Canadian prospective study of young women with breast cancer: the rationale and protocol design for the RUBY studyM L Quan, I A Olivotto, N N Baxter, et al.
Fa Yi Xue Za Zhi|December 13, 2017
[Correlation between Genetic Variants and Polymorphism of Caveolin and Sudden Unexplained Death]F Y Wu, X H Tang, L L Gai, et al.
Journal of Cardiovascular Pharmacology|September 1, 1995
Pharmacology of XR510, a potent orally active nonpeptide angiotensin II AT1 receptor antagonist with high affinity for the AT2 receptor subtypeP C Wong, M L Quan, J M Saye, et al.
The American Journal of Surgical Pathology|November 27, 2018
Distinct Genomic Patterns in Pigmented Epithelioid Melanocytoma: A Molecular and Histologic Analysis of 16 CasesMaria C Isales, Lauren S Mohan, Victor L Quan, et al.
Journal of the American Academy of Dermatology|October 6, 2018
The role of TERT promoter mutations in differentiating recurrent nevi from recurrent melanomas: A retrospective, case-control studyKara E Walton, Erin M Garfield, Bin Zhang, et al.
Journal of Thrombosis and Thrombolysis|August 8, 2015
In vitro, antithrombotic and bleeding time studies of BMS-654457, a small-molecule, reversible and direct inhibitor of factor XIaPancras C Wong, Mimi L Quan, Carol A Watson, et al.
Bioorganic & Medicinal Chemistry Letters|August 7, 2017
Macrocyclic factor XIa inhibitorsCailan Wang, James R Corte, Karen A Rossi, et al.
Bioorganic & Medicinal Chemistry Letters|March 5, 2018
Pyridazine and pyridazinone derivatives as potent and selective factor XIa inhibitorsZilun Hu, Cailan Wang, Wei Han, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|October 28, 2016
[Incidental internal mammary lymph node biopsy in 113 cases of breast cancer undergoingfree abdominal flap breast reconstruction and its influencing factors]C L Quan, N S Huang, B L Yang, et al.
Clinical and Experimental Dermatology|May 21, 2018
Immunohistochemical and molecular analysis of spitzoid neoplasms with pulverocyte subclonesS M Amin, A M Haugh, J A Bubley, et al.
Pageof 26